| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women JM Baeten, D Donnell, P Ndase, NR Mugo, JD Campbell, J Wangisi, ... New England journal of medicine 367 (5), 399-410, 2012 | 3822 | 2012 |
| Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders C Pop-Eleches, H Thirumurthy, JP Habyarimana, JG Zivin, MP Goldstein, ... Aids 25 (6), 825-834, 2011 | 1210 | 2011 |
| Psychological trauma and PTSD in HIV-positive women: a meta-analysis EL Machtinger, TC Wilson, JE Haberer, DS Weiss AIDS and Behavior 16 (8), 2091-2100, 2012 | 388 | 2012 |
| HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention D Donnell, JM Baeten, NN Bumpus, J Brantley, DR Bangsberg, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 66 (3), 340-348, 2014 | 386 | 2014 |
| Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention A Van der Straten, L Van Damme, JE Haberer, DR Bangsberg Aids 26 (7), F13-F19, 2012 | 352 | 2012 |
| Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies T Bärnighausen, K Chaiyachati, N Chimbindi, A Peoples, J Haberer, ... The Lancet infectious diseases 11 (12), 942-951, 2011 | 321 | 2011 |
| What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples NC Ware, MA Wyatt, JE Haberer, JM Baeten, A Kintu, C Psaros, S Safren, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (5), 463-468, 2012 | 304 | 2012 |
| Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm JE Haberer, DR Bangsberg, JM Baeten, K Curran, F Koechlin, KR Amico, ... Aids 29 (11), 1277-1285, 2015 | 299 | 2015 |
| High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk … EM Van der Elst, J Mbogua, D Operario, G Mutua, C Kuo, P Mugo, ... AIDS and Behavior 17, 2162-2172, 2013 | 295 | 2013 |
| Real-time adherence monitoring for HIV antiretroviral therapy JE Haberer, J Kahane, I Kigozi, N Emenyonu, P Hunt, J Martin, ... AIDS and Behavior 14, 1340-1346, 2010 | 254 | 2010 |
| Pediatric adherence to HIV antiretroviral therapy J Haberer, C Mellins Current HIV/AIDS Reports 6 (4), 194-200, 2009 | 245 | 2009 |
| Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa JE Haberer, JM Baeten, J Campbell, J Wangisi, E Katabira, A Ronald, ... PLoS medicine 10 (9), e1001511, 2013 | 243 | 2013 |
| Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities R Subbaraman, L de Mondesert, A Musiimenta, M Pai, KH Mayer, ... BMJ global health 3 (5), e001018, 2018 | 224 | 2018 |
| Preexposure prophylaxis for HIV prevention: where have we been and where are we going? JM Baeten, JE Haberer, AY Liu, N Sista JAIDS Journal of Acquired Immune Deficiency Syndromes 63, S122-S129, 2013 | 217 | 2013 |
| Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1–serodiscordant couples: a prospective implementation study in Kenya and Uganda JM Baeten, R Heffron, L Kidoguchi, NR Mugo, E Katabira, EA Bukusi, ... PLoS medicine 13 (8), e1002099, 2016 | 214 | 2016 |
| The Chinese free antiretroviral treatment program: challenges and responses F Zhang, JE Haberer, Y Wang, Y Zhao, Y Ma, D Zhao, L Yu, EP Goosby Aids 21, S143-S148, 2007 | 211 | 2007 |
| Improving antiretroviral therapy adherence in resource‐limited settings at scale: a discussion of interventions and recommendations JE Haberer, L Sabin, KR Amico, C Orrell, O Galárraga, AC Tsai, ... African Journal of Reproduction and Gynaecological Endoscopy 20 (1), 2017 | 195 | 2017 |
| Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda AC Tsai, DR Bangsberg, SM Kegeles, IT Katz, JE Haberer, C Muzoora, ... Annals of Behavioral Medicine 46 (3), 285-294, 2013 | 194 | 2013 |
| Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice JE Haberer Current Opinion in HIV and AIDS 11 (1), 10-17, 2016 | 191 | 2016 |
| Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting JE Haberer, J Kiwanuka, D Nansera, IB Wilson, DR Bangsberg AIDS and Behavior 14, 1294-1301, 2010 | 187 | 2010 |
